Skip to content

Clinical trials

Phase 3 Heart Failure trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: United Kingdom Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20064
20072
20081
20091
20114
20134
20144
20151
20162
20176
20185
20191
20202
20211
20231
20248
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting15
Terminated8
Unknown status6
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AstraZeneca6
Boehringer Ingelheim5
Bayer3
Colorado Prevention Center3
Novo Nordisk A/S3
Amgen2
Cytokinetics2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure61
Myocardial Infarction6
Cardiovascular Diseases5
Stroke3
Ventricular Dysfunction, Left3
Aortic Valve Stenosis2
Cardiomyopathies2
Cardiomyopathy, Dilated2
Coronary Artery Disease2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.